Literature DB >> 8439963

Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma.

Y Fujiwara1, M Emi, H Ohata, Y Kato, T Nakajima, T Mori, Y Nakamura.   

Abstract

We have examined loss of heterozygosity on the short arm of chromosome 8 in 133 colorectal carcinomas, using 20 restriction fragment length polymorphism markers. Loss of heterozygosity was observed in 58 (44%) of 131 tumors that were informative with at least one locus. Among these 58, 32 revealed a partial or interstitial deletion of chromosome 8p. Detailed deletion mapping of chromosome 8p in these tumors identified two distinct, commonly deleted regions. One was located between markers C18-266 and pSVL-LPL at 8p23.2-8p22, and the other between CI8-319 and CI8-494 at 8p21.3-8p11.22. The genetic lengths of these two intervals were estimated to be 28 and 18 cM, respectively. The results suggest that at least two tumor suppressor genes associated with colorectal carcinomas are present on chromosome 8p. Correlation of loss of heterozygosity on 8p to the clinicopathological stage was also detected, suggesting that inactivation of a tumor suppressor gene(s) on 8p plays a role in progression of colorectal carcinomas.

Entities:  

Mesh:

Year:  1993        PMID: 8439963

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

2.  RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis.

Authors:  Scott N Freeman; Yihong Ma; W Douglas Cress
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

3.  A unique human gene that spans over 230 kb in the human chromosome 8p11-12 and codes multiple family proteins sharing RNA-binding motifs.

Authors:  A Shimamoto; S Kitao; K Ichikawa; N Suzuki; Y Yamabe; O Imamura; Y Tokutake; M Satoh; T Matsumoto; J Kuromitsu; H Kataoka; K Sugawara; M Sugawara; M Sugimoto; M Goto; Y Furuichi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  N-acetyltransferase 2 genotype in colorectal cancer and selective gene retention in cancers with chromosome 8p deletions.

Authors:  A L Hubbard; D J Harrison; C Moyes; A H Wyllie; C Cunningham; E Mannion; C A Smith
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

Review 5.  What we could do now: molecular pathology of colorectal cancer.

Authors:  R S Houlston
Journal:  Mol Pathol       Date:  2001-08

Review 6.  Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Authors:  Philipp Ströbel; Alexander Marx; Andreas Zettl; Hans Konrad Müller-Hermelink
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Deletion mapping of chromosome 8p in colorectal carcinoma and dysplasia arising in ulcerative colitis, prostatic carcinoma, and malignant fibrous histiocytomas.

Authors:  M Chang; K Tsuchiya; R H Batchelor; P S Rabinovitch; B G Kulander; R C Haggitt; G C Burmer
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

8.  Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling.

Authors:  Sonia L Planey; Susan K Keay; Chen-Ou Zhang; David A Zacharias
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

9.  Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method.

Authors:  Jun Zhang; Sonia L Planey; Carolina Ceballos; Stanley M Stevens; Susan K Keay; David A Zacharias
Journal:  Mol Cell Proteomics       Date:  2008-02-22       Impact factor: 5.911

10.  Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum.

Authors:  J D Mueller; N Haegle; G Keller; E Mueller; G Saretzky; B Bethke; M Stolte; H Höfler
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.